• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重、肥胖和重度肥胖对澳大利亚成年人预期寿命的影响。

Impact of overweight, obesity and severe obesity on life expectancy of Australian adults.

机构信息

The George Institute for Global Health, University of New South Wales, Kensington, NSW, 2042, Australia.

The University of Sydney, Faculty of Medicine and Health, School of Public Health, Sydney, NSW, 2006, Australia.

出版信息

Int J Obes (Lond). 2019 Apr;43(4):782-789. doi: 10.1038/s41366-018-0210-2. Epub 2018 Oct 3.

DOI:10.1038/s41366-018-0210-2
PMID:30283076
Abstract

BACKGROUND/OBJECTIVES: Adult obesity has been shown to substantially heighten the risk of adverse health outcomes but its impact on life expectancy (LE) has not been quantified in Australia. Our aim is to estimate reductions in LE and years of life lost (YLL) associated with overweight and obesity, relative to those at a healthy weight for Australian adults aged 20-69 years.

SUBJECTS/METHODS: We used a microsimulation model of obesity progression in Australia that integrates annual change in BMI based on age and sex, with Australian life-table data and published relative risk of all-cause mortality for different BMI categories. Remaining LE and YLL compared to healthy weight were estimated using 10-year cohorts, by sex. A nationally representative sample of 12,091 adults aged 20-69 from the 2014/15 Australian National Health Survey were used to represent the input population of 14.9 million.

RESULTS

Estimated remaining years of LE for healthy weight men and women aged 20-29 years was approximately 57.0 (95% CI 56.7-57.4) and 59.7 (95% CI 59.4-60.0) years, respectively. YLL associated with being overweight at baseline was approximately 3.3 years. For those obese and severely obese the loss in LE was predicted to be 5.6-7.6 years and 8.1-10.3 years for men and women aged 20-29 years, respectively. Across men and women, excess BMI in the adult population is responsible for approximately 36.3 million YLLs. Men stand to lose 27.7% more life years compared to women.

CONCLUSIONS

Overweight and obesity is associated with premature mortality at all ages, for both men and women. Adults aged 20-39 years with severe obesity will experience the largest YLL, relative to healthy weight. More needs to be done in Australia to establish a coherent, sustained, cost-effective strategy to prevent overweight and obesity, particularly for men in early adulthood.

摘要

背景/目的:成人肥胖已被证明会大大增加不良健康后果的风险,但尚未在澳大利亚量化其对预期寿命(LE)的影响。我们的目的是估计澳大利亚 20-69 岁成年人超重和肥胖相对于健康体重的 LE 减少和生命损失年(YLL)。

方法

我们使用了澳大利亚肥胖进展的微观模拟模型,该模型将 BMI 的年度变化与年龄和性别结合在一起,结合了澳大利亚生命表数据和不同 BMI 类别全因死亡率的已发表相对风险。通过按性别对 10 年队列进行比较,估算与健康体重相比剩余的 LE 和 YLL。使用来自 2014/15 年澳大利亚国家健康调查的 12091 名 20-69 岁成年人的全国代表性样本来代表 1490 万输入人群。

结果

估计健康体重的 20-29 岁男性和女性的剩余 LE 约为 57.0(95%CI 56.7-57.4)和 59.7(95%CI 59.4-60.0)年。基线超重的 YLL 约为 3.3 年。对于 20-29 岁的男性和女性肥胖和重度肥胖,LE 丧失预计分别为 5.6-7.6 年和 8.1-10.3 年。在男性和女性中,成年人的超重和肥胖导致大约 3630 万 YLL。与女性相比,男性损失的生命年数多 27.7%。

结论

超重和肥胖与所有年龄段的过早死亡有关,无论男女。患有严重肥胖症的 20-39 岁成年人相对于健康体重,将经历最大的 YLL。澳大利亚需要采取更多措施,制定一致、持续、具有成本效益的策略来预防超重和肥胖,尤其是在年轻人中。

相似文献

1
Impact of overweight, obesity and severe obesity on life expectancy of Australian adults.超重、肥胖和重度肥胖对澳大利亚成年人预期寿命的影响。
Int J Obes (Lond). 2019 Apr;43(4):782-789. doi: 10.1038/s41366-018-0210-2. Epub 2018 Oct 3.
2
Years of life lost due to obesity.肥胖导致的寿命损失年数。
JAMA. 2003 Jan 8;289(2):187-93. doi: 10.1001/jama.289.2.187.
3
Individual and aggregate years-of-life-lost associated with overweight and obesity.与超重和肥胖相关的个体和总体生命损失年数。
Obesity (Silver Spring). 2010 Feb;18(2):333-9. doi: 10.1038/oby.2009.253. Epub 2009 Aug 13.
4
Counting the lifetime cost of obesity: Analysis based on national England data.计算肥胖的终身成本:基于英国全国数据的分析。
Diabetes Obes Metab. 2024 Apr;26(4):1464-1478. doi: 10.1111/dom.15447. Epub 2024 Feb 5.
5
BMI and healthy life expectancy in old and very old women.老年及高龄女性的体重指数与健康预期寿命
Br J Nutr. 2016 Aug;116(4):692-9. doi: 10.1017/S0007114516002403. Epub 2016 Jun 16.
6
Population-Based Estimates of Decreases in Quality-Adjusted Life Expectancy Associated with Unhealthy Body Mass Index.基于人群的与不健康体重指数相关的质量调整生命预期下降的估计
Public Health Rep. 2016 Jan-Feb;131(1):177-84. doi: 10.1177/003335491613100125.
7
Impact of overweight and obesity on life expectancy, quality-adjusted life years and lifetime costs in the adult population of Ghana.超重和肥胖对加纳成年人口预期寿命、质量调整生命年和终生成本的影响。
BMJ Glob Health. 2020 Sep;5(9). doi: 10.1136/bmjgh-2020-003332.
8
Excess weight and life expectancy after acute myocardial infarction: The obesity paradox reexamined.急性心肌梗死后的超重与预期寿命:对肥胖悖论的重新审视。
Am Heart J. 2016 Feb;172:173-81. doi: 10.1016/j.ahj.2015.10.024. Epub 2015 Dec 1.
9
Ethnic differences in overweight and obesity and the influence of acculturation on immigrant bodyweight: evidence from a national sample of Australian adults.超重和肥胖方面的种族差异以及文化适应对移民体重的影响:来自澳大利亚成年人全国样本的证据。
BMC Public Health. 2016 Sep 5;16(1):932. doi: 10.1186/s12889-016-3608-6.
10
Life expectancy and life expectancy with disability of normal weight, overweight, and obese smokers and nonsmokers in Europe.欧洲正常体重、超重和肥胖吸烟者与非吸烟者的预期寿命和残疾预期寿命。
Obesity (Silver Spring). 2011 Jul;19(7):1451-9. doi: 10.1038/oby.2011.46. Epub 2011 Mar 17.

引用本文的文献

1
Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals?肥胖症的药物治疗:我们是否准备好选择、定制和联合药物治疗以实现更宏伟的目标?
Front Endocrinol (Lausanne). 2025 Jun 18;16:1569468. doi: 10.3389/fendo.2025.1569468. eCollection 2025.
2
Effect of Lekhan Basti and Navak Guggul on lipid markers and transcriptional effects of selected genes in obese patients: A single-centre, open-labelled, randomized, comparative, pilot study.勒汗巴斯提和纳瓦克古古勒对肥胖患者血脂标志物及所选基因转录效应的影响:一项单中心、开放标签、随机、对照、试点研究。
J Ayurveda Integr Med. 2025 May 29;16(3):101129. doi: 10.1016/j.jaim.2025.101129.
3
Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
1990年至2021年全球、区域和国家成人超重和肥胖患病率及到2050年的预测:全球疾病负担研究2021的一项预测研究
Lancet. 2025 Mar 8;405(10481):813-838. doi: 10.1016/S0140-6736(25)00355-1. Epub 2025 Mar 3.
4
Experiencing Food Restrictions for Health and Weight Control in Childhood and Their Links to Restrained Eating and Excessive Body Weight in Polish Young Adults-A Cross-Sectional Study.波兰年轻人童年时期因健康和体重控制而经历的食物限制及其与克制性饮食和超重的关联——一项横断面研究
Nutrients. 2024 Dec 29;17(1):87. doi: 10.3390/nu17010087.
5
Pharmacological Treatment of Obesity in Older Adults.老年人肥胖的药物治疗。
Drugs Aging. 2024 Nov;41(11):881-896. doi: 10.1007/s40266-024-01150-9. Epub 2024 Nov 8.
6
Dental team barriers and enablers for the dental management of adults with severe obesity: a qualitative analysis.牙科团队在重度肥胖成年人牙科管理中的障碍与促进因素:一项定性分析
BDJ Open. 2024 Nov 2;10(1):83. doi: 10.1038/s41405-024-00264-x.
7
Reverse epidemiology of obesity paradox: Fact or fiction?肥胖悖论的反向流行病学:事实还是虚构?
Physiol Rep. 2024 Nov;12(21):e70107. doi: 10.14814/phy2.70107.
8
Investigating factors influencing overweight and obesity among adult households in Ethiopia: a multilevel ordered analysis of 2016 EDHS data.调查影响埃塞俄比亚成年家庭超重和肥胖的因素:对 2016 年 EDHS 数据的多层次有序分析。
Front Endocrinol (Lausanne). 2024 Oct 14;15:1408090. doi: 10.3389/fendo.2024.1408090. eCollection 2024.
9
Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis.益生菌、益生元、合生元及其他基于微生物群的创新疗法,通过肠-脑轴减轻肥胖并延长寿命。
Microbiome Res Rep. 2024 May 17;3(3):29. doi: 10.20517/mrr.2024.05. eCollection 2024.
10
Comparison of race- and ethnicity-specific BMI cutoffs for categorizing obesity severity: a multicountry prospective cohort study.比较种族和族裔特异性 BMI 切点用于分类肥胖严重程度的多国家前瞻性队列研究。
Obesity (Silver Spring). 2024 Oct;32(10):1958-1966. doi: 10.1002/oby.24129. Epub 2024 Sep 3.